Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

American College of Rheumatology Simple Tasks Campaign Marks One Year

Carol Patton  |  September 5, 2012

Campaign raises awareness about rheumatologists and rheumatic diseases.

EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus

Thomas R. Collins  |  September 5, 2012

MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.

Why We Are Advocates

James R. O’Dell, MD  |  September 5, 2012

Rheumatology advocacy efforts are paying off in 2012.

Life, Happiness, and the Pursuit of Rheumatology

Simon M. Helfgott, MD  |  September 5, 2012

What makes rheumatologists such a happy group?

ACR/ARHP Annual Meeting Networking

Staff  |  September 5, 2012

The 2012 ACR/ARHP Annual Meeting is an opportunity to network with rheumatology colleagues from around the world.

American College of Rheumatology Award Provides Researchers Time for Career Development

Staff  |  September 5, 2012

The ACR Research and Education Foundation (REF) initiated the ACR REF Rheumatology Investigator Award, which supports junior investigators as they are developing a project that will compete for NIH funding.

Join 125 Colleagues and Patients to Bring Rheumatology’s Message to Capitol Hill

Staff  |  September 5, 2012

Rheumatology professionals and patients attending the ACR’s Advocates for Arthritis conference will convene on Capitol Hill to speak with lawmakers about issues affecting the rheumatology community.

New Fraud Detection Probes by Medicare

Staff  |  September 5, 2012

The National Fraud Prevention Program aims to cut the rate of improper payment claims in half.

EULAR 2012: Rewards in Risk Factor Research

Thomas R. Collins  |  September 5, 2012

Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.

Drug Diversion Concerns on the Rise

Kurt Ullman  |  September 5, 2012

Medications removed from legitimate supply channels can affect both physician and patient.

  • « Previous Page
  • 1
  • …
  • 250
  • 251
  • 252
  • 253
  • 254
  • …
  • 307
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences